Cyclosporine is an immunosuppressant medicine and natural product administered via injection and mouth into veins for the treatment of rheumatoid psoriasis, arthritis, nephrotic syndrome, Crohn's disease, and in organ transplants to prevent rejection.
In addition, it is used as eye drops for dry eyes. Ciclosporin was extracted from the fungus Tolypocladium inflatum, and was eventually used for medicinal purposes.

The global Cyclosporine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Cyclosporine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cyclosporine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cyclosporine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cyclosporine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Alcon
Allergan
Herantis Pharma
Mimetogen Pharmaceuticals
Mitotech
Otsuka Pharmaceutical
Regenerx Biopharmaceuticals
Santen Pharmaceutical
Shire
United Biotech

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Pills
Oral Liquid

Segment by Application
Hospital
Clinic